Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

The 'one dose fits all' approach to aspirin

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 29.01.20
Views: 125
Rating:

Prof Peter Rothwell - University of Oxford, Oxford, UK

Prof Peter Rothwell speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about current guidelines that use a 'one dose fits all' approach when it comes to aspirin.

Prof Rothwell explains that this recommended dose often differs between countries, so there is no one agreed-upon dose or dosing regimen that is universally recommended. Furthermore, he explains that other factors need to be considered for each patient.

He concludes that a 'one dose fits all' or a 'one frequency of dosing' fits all approach is not likely to be the best approach.

Read more on the highlights from the 2019 International Aspirin Foundation Scientific Conference here.

Related videos

follow us

Biosimilar Medicines Core Principles and Communication


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation